America is dismantling its institutional immune system
As international disease surveillance is weakened, it is vital that Australia invests in its national health infrastructure.
As international disease surveillance is weakened, it is vital that Australia invests in its national health infrastructure.
Cost-of-living pressures dominate public priorities and major policy focus this election, along with a strong undercurrent of political unease from the United States. As voters appear to be searching for a reassuring alternative to global issues, health care is once again a critical bargaining chip, with the three major parties going all in.
As the Trump administration continues its program of “reciprocal tariffs” and the pharmaceutical industry calls out the Pharmaceutical Benefits Scheme (PBS) and generic drugs, Australian health experts say that Australia must preserve the current system.
Less than two months from an election, the Albanese government last night presented a budget that aims to swing the voting pendulum its way.
The new Trump Administration has wasted no time in implementing its destructive agenda on matters that are of importance to human health – including climate policies, mining expansion, and tariffs on many health items including pharmaceuticals.
The global scientific and medical community finds itself witnessing authoritarian acts in the United States. In the last few weeks, the Trump administration has ordered the United States Centre for Disease Control and Prevention (CDC) to pause publications, recall research, and has moved to censor words including “LGBT” from government publications and research grant applications.